Drawing for LONGBOARD

USPTO serial 90232096

LONGBOARD

Reviewed by CopyMark Law Group

Reg. 6761470Status 700Registered
Filing date
Status date
Registration date
Jun 14, 2022
Examiner
GALBO, AMANDA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with LONGBOARD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maren C. Perry

Maren C. Perry King & Spalding LLP1185 Avenue of the AmericasNew York, NY 10036United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and pharmaceutical compounds for the treatment of disorders of the central nervous systemACTIVEMar 10, 2022
042Scientific and technological services, namely, medical research, scientific research and analysis in the field of pharmaceuticals and biomedicine; pharmaceutical and biomedical research services; scientific research in the fields of pharmaceutical preparations, clinical trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine and clinical trials; research and development services in the fields of pharmaceuticals and biotechnology; scientific research and development; laboratory research, screening, evaluation, development and clinical testing of therapeutic compounds; scientific research, studies, and development in the field of pharmaceuticals; scientific research and development, namely, pharmaceutical discovery, process development relating to synthesis and scalability for active pharmaceutical ingredients, large scale synthesis of active pharmaceutical ingredients, and formulation developmentACTIVEOct 27, 2020
044Providing medical informationACTIVEMar 28, 2022

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 17, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 17, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 17, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 17, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 17, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 14, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 14, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 10, 2022SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
May 8, 2022CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
May 5, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 5, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 5, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 5, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 5, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 4, 2022ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
May 4, 2022SUPCSTATEMENT OF USE PROCESSING COMPLETE—
May 2, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 18, 2022IUAFUSE AMENDMENT FILED—
Apr 18, 2022EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jan 4, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 9, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 9, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 20, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 1, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 1, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Oct 1, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 1, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 1, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 4, 2021GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Mar 4, 2021GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Mar 4, 2021CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Mar 1, 2021DOCKASSIGNED TO EXAMINER—
Nov 17, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 6, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance